Zostavax and Shingrix are linked to protection for older adults in multiple studies.

A single-dose of the respiratory syncytial virus (RSV) vaccine in older adults showed waning efficacy across three seasons of ...

GSK plc announced that the US Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization Practices (ACIP) has voted to recommend use of Penmenvy (Meningococcal Groups A, B, ...

PHILADELPHIA, PA — The Advisory Committee on Immunization Practices (ACIP) has voted to expand the recommended use of GSK’s ...

GSK has become the first pharma company to get regulatory approval for a vaccine against respiratory syncytial virus (RSV), setting up what looks set to be a highly lucrative – and likely ...

The U.S. Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization Practices (ACIP) has ...

GSK has upgraded its longstanding alliance with CureVac on mRNA-based vaccines for respiratory infections, paying €400 million ($429 million) upfront for global rights to its influenza and COVID ...

Next year’s COVID vaccine recommendations from the U.S. Centers for Disease Control and Prevention appear likely to be less expansive than in previous years. Notes from a recent meeting of the ...

DTaP and Tdap are combination vaccines that protect against tetanus, diphtheria and whooping cough. DTaP is given to infants and young children, whereas Tdap is administered to anyone above the ...

A new global study led by GlaxoSmithKline has found that a single dose of the RSV vaccine Arexvy (RSVPreF3 OA) offers strong ...

HAPPY FRIDAY. IT’S GREAT TO SEE YOU. AS YOU KNOW, VACCINES HAVE BEEN A FREQUENT TARGET IN THE DEBATE ABOUT AUTISM. SO SO JUST TO JUST TO WE’LL BUILD A BASE. FIRST. TELL US AGAIN WHAT DOES WHAT ...